Sarah R Young1, Soraya Azari, William C Becker, E Jennifer Edelman, Jane M Liebschutz, Payel Roy, Joanna L Starrels, Jessica S Merlin. 1. Department of Social Work, College of Community and Public Affairs, Binghamton University, Binghamton, NY (SRY); University of California, San Francisco, CA (SA); VA Connecticut Healthcare System, West Haven, CT (WCB); Yale School of Medicine, New Haven, CT (WCB, EJE); University of Pittsburgh Department of Medicine, Pittsburgh, PA (JML, JSM); Boston Medical Center, Boston University School of Medicine, Boston, MA (PR); Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY (JLS).
Abstract
OBJECTIVE: Long-term opioid therapy (LTOT) is commonly prescribed for chronic pain, despite risks such as opioid use disorder (OUD) and overdose. Caring for patients on LTOT can be difficult, given lack of evidence about assessment of challenging behaviors among patients on LTOT. To develop this evidence, a critical first step is to systematically identify the common and challenging behaviors that primary care providers encounter among patients on LTOT, and also to highlight to diverse range of behaviors encountered. METHOD: We conducted a Delphi study in 42 chronic pain experts to determine consensus on how to address the top common and challenging behaviors. This paper reports on the first round of the study, which elicited a range of behaviors. We conducted thematic analysis of the behaviors and also used the Diagnostic and Statistical Manual (DSM)-5 criteria for OUD as a priori codes. RESULTS: In all, 124 unique behaviors were identified by participants and coded into 4 thematic categories: concerning behaviors that map onto DSM-5 criteria for OUD, and those that do not which were: behaviors that suggest deception, signs of diversion, and nonadherence to treatment plan. Those behaviors that fell outside of OUD criteria we identified as "gray zone" behaviors. CONCLUSIONS: While some of these challenging behaviors fall under the criteria for an OUD, many fall outside of this framework, making diagnosis and treatment difficult, and consensus on how to deal with these "gray zone" behaviors is vital. Future research should explore how these "gray zone" behaviors can best be assessed and managed in a primary care setting.
OBJECTIVE: Long-term opioid therapy (LTOT) is commonly prescribed for chronic pain, despite risks such as opioid use disorder (OUD) and overdose. Caring for patients on LTOT can be difficult, given lack of evidence about assessment of challenging behaviors among patients on LTOT. To develop this evidence, a critical first step is to systematically identify the common and challenging behaviors that primary care providers encounter among patients on LTOT, and also to highlight to diverse range of behaviors encountered. METHOD: We conducted a Delphi study in 42 chronic pain experts to determine consensus on how to address the top common and challenging behaviors. This paper reports on the first round of the study, which elicited a range of behaviors. We conducted thematic analysis of the behaviors and also used the Diagnostic and Statistical Manual (DSM)-5 criteria for OUD as a priori codes. RESULTS: In all, 124 unique behaviors were identified by participants and coded into 4 thematic categories: concerning behaviors that map onto DSM-5 criteria for OUD, and those that do not which were: behaviors that suggest deception, signs of diversion, and nonadherence to treatment plan. Those behaviors that fell outside of OUD criteria we identified as "gray zone" behaviors. CONCLUSIONS: While some of these challenging behaviors fall under the criteria for an OUD, many fall outside of this framework, making diagnosis and treatment difficult, and consensus on how to deal with these "gray zone" behaviors is vital. Future research should explore how these "gray zone" behaviors can best be assessed and managed in a primary care setting.
Authors: Ellen C Meltzer; Dennis Rybin; Lidia Z Meshesha; Richard Saitz; Jeffrey H Samet; Sonia L Rubens; Jane M Liebschutz Journal: Pain Med Date: 2012-10-11 Impact factor: 3.750
Authors: Paula J Lum; Sherri Little; Michael Botsko; David Hersh; Robert E Thawley; James E Egan; Jennifer Mitty; Joshua Boverman; David A Fiellin Journal: J Acquir Immune Defic Syndr Date: 2011-03-01 Impact factor: 3.731
Authors: Jessica S Merlin; Janet M Turan; Ivan Herbey; Andrew O Westfall; Joanna L Starrels; Stefan G Kertesz; Michael S Saag; Christine S Ritchie Journal: Pain Med Date: 2014-08-19 Impact factor: 3.750
Authors: Steven K Dobscha; Kathryn Corson; Jennifer A Flores; Erin C Tansill; Martha S Gerrity Journal: Pain Med Date: 2008 Jul-Aug Impact factor: 3.750
Authors: Kevin E Vowles; Mindy L McEntee; Peter Siyahhan Julnes; Tessa Frohe; John P Ney; David N van der Goes Journal: Pain Date: 2015-04 Impact factor: 6.961
Authors: Jessica S Merlin; Sarah R Young; Soraya Azari; William C Becker; Jane M Liebschutz; Jamie Pomeranz; Payel Roy; Shalini Saini; Joanna L Starrels; E Jennifer Edelman Journal: BMJ Open Date: 2016-05-06 Impact factor: 2.692
Authors: Gery P Guy; Kun Zhang; Michele K Bohm; Jan Losby; Brian Lewis; Randall Young; Louise B Murphy; Deborah Dowell Journal: MMWR Morb Mortal Wkly Rep Date: 2017-07-07 Impact factor: 17.586
Authors: Pooja Lagisetty; Claire Garpestad; Angela Larkin; Colin Macleod; Derek Antoku; Stephanie Slat; Jennifer Thomas; Victoria Powell; Amy S B Bohnert; Lewei A Lin Journal: Drug Alcohol Depend Date: 2021-02-13 Impact factor: 4.492